Medspira

What Medspira does

Medspira, LLC is a Minneapolis-based private medical device company founded in 2009 that manufactures the mcompass platform, a portable (~3-pound), wireless, tablet-based system for anorectal manometry diagnostics and manometric biofeedback therapy. The device uses disposable five-channel balloon catheters — with four sensors around the anal canal and one in the rectum — to perform diagnostic pressure measurements and pelvic floor retraining in approximately 15 minutes without a dedicated room, with results shareable via encrypted built-in WiFi. Medspira holds two FDA 510(k) clearances (K120088 for the manometry system, K143031 for the biofeedback system), is ISO 13485 compliant, and holds five patents co-invented by CEO Evan Johnston.

The company sells the mcompass hardware directly to gastroenterology and colorectal clinics, OB/GYN practices, geriatric and nursing-home care settings, pediatric gastroenterology programs, and primary care practices, and it distributes disposable catheters and accessories through an online storefront. A Premier, Inc. group purchasing agreement effective February 2022 extends institutional reach across the US healthcare market, which is currently Medspira's only cleared geography. The revenue model combines one-time capital equipment sales with recurring consumable revenue from disposable catheters (two-year shelf life), and the company's marketing materials emphasize CPT reimbursement economics — CPT 91125 for anorectal manometry ($700-$1,100 per exam) plus 90912 and 90913 for biofeedback therapy — that can yield customers roughly $600K in annual practice revenue.

With 11-50 employees and a founder-led management team (Evan Johnston as CEO, Mohamed Nouri as Founder and VP of Sales, supported by an advisory board including Mayo Clinic emeritus faculty and biomedical engineering academics), Medspira positions itself as a smaller, innovative challenger to incumbent high-resolution manometry vendors such as Laborie and Medtronic by focusing on office-based portability, disposable consumables, and a sub-3-month customer ROI rather than competing in hospital-based systems.

Name

Medspira

Legal name

Medspira, LLC

Website

https://medspira.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Medspira manufactures the portable, wireless mcompass anorectal manometry and biofeedback system for office-based gastroenterology, colorectal, OB/GYN, pediatric, and primary care practices in the United States.

Ownership category

akta.pro rank

Headquarters

HQ city

Minneapolis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of mcompass anorectal manometry systems to healthcare clinics and practices. The device is a one-time capital purchase with disposable consumables for ongoing procedures.
2. Disposable Catheters and Consumables: Recurring revenue from disposable catheters and accessories sold through the online shop (shop.medspira.com). Catheters carry a 2-year shelf life.
3. Clinical Procedure Reimbursements: Healthcare providers bill CPT codes 91125 (Anorectal manometry), 90912 (Biofeedback training, initial 15 minutes), and 90913 (Biofeedback training, subsequent 15 minutes) for procedures performed with the device.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Medspira designs, manufactures, and sells the mcompass portable, wireless anorectal manometry and manometric biofeedback therapy system for office-based use. The core offering combines a tablet-based hardware device with disposable catheters that measure rectal and anal sphincter pressures simultaneously across five channels, supporting both diagnosis of fecal incontinence, chronic constipation, and pelvic floor dysfunction, as well as biofeedback therapy for pelvic floor muscle retraining. Recurring revenue comes from disposable catheter and accessory sales through the company's online store.

Product overview

Medspira offers a unified product ecosystem centered on the mcompass device platform, which provides both anorectal manometry diagnostics and manometric biofeedback therapy capabilities. The core mcompass system serves as a portable, wireless diagnostic and therapeutic device for evaluating and treating pelvic floor and anorectal disorders. The platform supports two primary modes: the mcompass Anorectal Manometry System for diagnostic testing of anal sphincter function, rectal sensation, and coordination, and the mcompass Manometric Biofeedback System for therapeutic pelvic floor muscle retraining. The product line includes specialized Petite Catheters for pediatric patients, the Lite Version software for remote report interpretation, and the Quick RAIR test as part of its diagnostic suite. All products use disposable catheters with a tablet-based interface.

Differentiator

Problem solved

Functional benefit

Brands

• mcompass: The primary product brand for anorectal manometry and manometric biofeedback therapy devices. mcompass is FDA cleared and is described as a portable, wireless system for anorectal diagnostics and pelvic floor biofeedback therapy.

Products and services

• mcompass Anorectal Manometry System A portable, wireless, tablet-based anorectal manometry device designed for office-based diagnostic testing of anorectal function. The system measures pressures in the anal canal and rectum to diagnose fecal incontinence, chronic constipation, and pelvic floor dysfunction using disposable catheters and a tablet interface, intended for gastroenterology, colorectal, OB/GYN, pediatric, and primary care practices.
• mcompass Manometric Biofeedback System An FDA-cleared portable biofeedback therapy device that uses pressure sensors to provide real-time feedback for pelvic floor muscle retraining. The system helps patients with urinary incontinence, chronic constipation, and incontinence related to childbirth and other traumas through visual biofeedback and four comprehensive pelvic floor retraining exercises, intended for the same office-based practices as the manometry system.
• Petite Catheters Smaller-sized disposable catheters designed specifically for pediatric patients and small adults as part of the mcompass product line. Features a shorter distal tip, shorter functional length, smaller diameter rectal balloon, and 5-channel configuration optimized for comfortable diagnosis of lower GI disorders in children, sold through the company's online store.
• Standard Disposable Catheters and Accessories Recurring disposable catheters and accessory supplies for the mcompass Anorectal Manometry and Biofeedback Systems, sold through the Medspira online store (shop.medspira.com). Catheters carry a 2-year shelf life and are designed for ready-to-use operation without calibration or sterilization.

Named customers3 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Two partnerships are on record, tiered core.

• Premier, Inc.coreChannel Partner/ Reseller/ Distributor · 1 February 2022Medspira was awarded a group purchasing agreement with Premier, Inc., effective February 1, 2022. The agreement allows Premier members to access special pricing and terms pre-negotiated by Premier for the Medspira mcompass device, expanding distribution reach to Premier's network of healthcare facilities.
• FDA-Cleared and ISO 13485 Registered Manufacturing FacilitiescoreOthersMedspira products are produced in partnership with world-class, FDA cleared and ISO 13485 registered manufacturing facilities, providing high-quality products and fast time-to-market.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Laborie Medical Technologies: Laborie is the global market leader in pelvic floor diagnostics with 24–28% share, offering a portfolio of high-resolution anorectal manometry and urodynamic systems. It is the closest direct competitor to Medspira's mcompass in clinical GI motility diagnostics, but historically focuses on hospital-based, larger-form-factor systems.
• The Prometheus Group: Prometheus holds 11–14% share of pelvic floor diagnostics and sells high-resolution anorectal and esophageal manometry systems. It competes head-to-head with Medspira in motility diagnostics for gastroenterology practices, though it lacks a portable, office-based system comparable to mcompass.
• Diversatek Healthcare: Diversatek (formerly Sandhill Scientific) manufactures high-resolution esophageal and anorectal manometry systems. It is a direct competitor in motility diagnostics, primarily serving hospital GI labs and gastroenterology specialty practices with cart-based systems analogous to those Medspira aims to displace.

Broad incumbents

• Medtronic: Medtronic holds 18–22% share of the pelvic floor diagnostics market through its GI solutions franchise. While Medspira competes with a narrow product focus, Medtronic is a multi-billion-dollar diversified medtech incumbent whose manometry systems, sales reach, and capital resources make it the most consequential broad incumbent competitor.
• Laborie / GI Logic (InnoVision): Laborie's broader motility and GI Logic ecosystem (formerly known as the Sandhill/InnoVision product lines) provides a wide portfolio of anorectal manometry hardware and software used by hospital GI labs. Comparable to Medspira at the clinical workflow level though primarily serving larger hospital settings.

Emerging players

• Mui Scientific: Mui Scientific specializes in manometry catheters and accessories for GI and urodynamic applications. As a niche, catheter-focused competitor, it overlaps with Medspira on the disposable side of the anorectal manometry workflow and could be a supply-side competitor for catheter tenders.
• Cogentix Medical (now part of Laborie): Cogentix developed urology and pelvic floor diagnostic and therapeutic products (including the Urgent PC system). Its historical focus on office-based pelvic floor care overlaps with Medspira's positioning and is now part of the Laborie ecosystem.
• Pelvalon: Pelvalon developed the Eclipse System, a non-surgical vaginal insert for fecal incontinence. While not a direct manometry competitor, it addresses the same downstream patient population (fecal incontinence) and serves overlapping colorectal/gyn practice channels, making it a clinical pathway peer.
• BlueWind Medical: BlueWind develops implantable neuromodulation for pelvic floor disorders. It is an adjacent competitor in the broader pelvic floor therapy market and overlaps with Medspira on biofeedback/pelvic floor retraining patient pathways.

Others

• Steris / Cantel Medical (endoscopy reprocessing adjacency): While not a direct manometry competitor, Steris is a major medtech incumbent in GI procedure-room consumables and reprocessing. It is relevant as a broad incumbent that could leverage its hospital distribution muscle to enter or bundle anorectal manometry, representing an indirect competitive threat.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/medspira
• Xx.com/Medspira
• Facebookfacebook.com/medspira

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medspira